Chronic levetiracetam treatment early in life decreases epileptiform events in young GAERS, but does not prevent the expression of spike and wave discharges during adulthood

Seizure

Volumn 14, Issue 6, 2005, Pages 403-411

  Dedeurwaerdere, Stefanie ^a   Boon, Paul ^a   De Smedt, Tim ^a   Claeys, Pieter ^a   Raedt, Robrecht ^a   Bosman, Tommy ^a   Van Hese, Peter ^a,b   Van Maele, Georges ^a   Vonck, Kristl ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Absence epilepsy; Anti epileptogenic; GAERS; Levetiracetam; Spike and wave discharges (SWDs)

Indexed keywords

ETIRACETAM; SODIUM CHLORIDE;

ABSENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ELECTROCORTICOGRAPHY; EPILEPTIC DISCHARGE; FEMALE; FOLLOW UP; GENETIC SUSCEPTIBILITY; LONG TERM CARE; MALE; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; RAT; RAT STRAIN; SEIZURE SUSCEPTIBILITY; SPIKE WAVE; TREATMENT OUTCOME;

AGING; ANIMALS; ANTICONVULSANTS; BRAIN; ELECTRODES, IMPLANTED; ELECTROENCEPHALOGRAPHY; EPILEPSY; PIRACETAM; RATS; RATS, INBRED STRAINS;

EID: 23944466596     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2005.07.001     Document Type: Article

References (34)

1. W.A. Hauser Incidence and prevalence. In: J. Engel, T.A. Pedley, editors. Epilepsy, a comprehensive textbook 1998 Lippincot-Raven Philadelphia p. 47-58
2. P. Kwan M.J. Brodie Early identification of refractory epilepsy N Engl J Med 342 2000 314-319
3. J.M. Silver C. Shin J.O. McNamara Antiepileptogenic effects of conventional anticonvulsants in the kindling model of epilespy Ann Neurol 29 4 1991 356-363
4. S.C. Stratton C.H. Large B. Cox G. Davies R.M. Hagan Effects of lamotrigine and levetiracetam on seizure development in a rat amygdala kindling model Epilepsy Res 53 2003 95-106
5. V. Andre M.A. Rigoulot E. Koning A. Ferrandon A. Nehlig Long-term pregabalin treatment protects basal cortices and delays the occurrence of spontaneous seizures in the lithium-pilocarpine model in the rat Epilepsia 44 2003 893-903
6. A. Fernandez-Guardiola A. Martinez A. Valdes-Cruz V.M. Magdaleno-Madrigal D. Martinez R. Fernandez-Mas Vagus nerve prolonged stimulation in cats: Effects on epileptogenesis (amygdala electrical kindling): Behavioral and electrographic changes Epilepsia 40 1999 822-829
7. W. Loscher D. Honack C. Rundfeldt Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy J Pharmacol Exp Ther 284 1998 474-479
8. M. Sasa H. Yan T. Nagayama T. Seriwaka Anti-epileptogenic properties of levetiracetam in the spontaneously epileptic rat (SER) Epilepsia 44 Suppl. 8 2003 175-176
9. J.J. Cereghino V. Biton B. Abou Khalil F. Dreifuss L.J. Gauer I. Leppik Levetiracetam for partial seizures: Results of a double-blind, randomized clinical trial Neurology 55 2000 236-242
10. S.D. Shorvon A. Lowenthal D. Janz E. Bielen P. Loiseau Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group Epilepsia 41 2000 1179-1186
11. W. Loscher D. Honack Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats Eur J Pharmacol 232 1993 147-158
12. W. Loscher E. Reissmuller U. Ebert Anticonvulsant efficacy of gabapentin and levetiracetam in phenytoin-resistant kindled rats Epilepsy Res 40 2000 63-77
13. M. Glien C. Brandt H. Potschka W. Loscher Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe Epilepsia 43 2002 350-357
14. A.J. Gower E. Hirsch A. Boehrer M. Noyer C. Marescaux Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy Epilepsy Res 22 1995 207-213
15. A. Pitkanen Drug-mediated neuroprotection and antiepileptogenesis: animal data Neurology 59 2002 27-33
16. P. Boon L. Seys K. Vonck S. Dedeurwaerdere M. D'Havé T. Grisar et al. The effect of levetiracetam in genetic absence epilepsy Strasbourg rats Epilepsia 43 2002 60
17. B.M. Bouwman C.M. van Rijn Effects of levetiracetam on spike and wave discharges in WAG/Rij rats Seizure 13 2004 591-594
18. L. Danober C. Deransart A. Depaulis M. Vergnes C. Marescaux Pathophysiological mechanisms of genetic absence epilepsy in the rat Prog Neurobiol 55 1998 27-57
19. M.A. Rigoulot A. Boehrer A. Nehlig Effects of topiramate in two models of genetically determined generalized epilepsy, the GAERS and the audiogenic Wistar AS Epilepsia 44 2003 14-19
20. J.-P.A. Manning D.A. Richards N. Leresche V. Crunelli N.G. Bowery Cortical-area specific block of genetically determined absence seizures by ethosuximide Neuroscience 123 2004 5-9
21. P. Van Hese J.P. Martens P. Boon S. Dedeurwaerdere I. Lemahieu R Van de Walle Detection of spike and wave discharges in the cortical EEG of genetic absence epilepsy rats from Strasbourg Phys Med Biol 48 2003 1685-1700
22. H. Kupferberg Animal models used in the screening of antiepileptic drugs Epilepsia 42 2001 7-12
23. H. Klitgaard A. Pitkanen Antiepileptogenesis, neuroprotection, and disease modification in the treatment of epilepsy: Focus on levetiracetam Epileptic Disord 5 Suppl. 1 2003 9-16
24. W. Loscher D. Honack Development of tolerance during chronic treatment of kindled rats with the novel antiepileptic drug levetiracetam Epilepsia 41 2000 1499-1506
25. H. Klitgaard A. Matagne J. Gobert E. Wulfert Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy Eur J Pharmacol 353 1998 191-206
26. P.N. Patsalos Pharmacokinetic profile of levetiracetam: Toward ideal characteristics Pharmacol Ther 85 2000 77-85
27. M.S. Benedetti Enzyme induction and inhibition by new antiepileptic drugs: A review of human studies Fundam Clin Pharmacol 14 2000 301-319
28. A. Nehlig A. Boehrer Effects of remacemide in two models of genetically determined generalized epilepsy, the GAERS and the audiogenic Wistar AS Epilepsy Res 52 2003 253-261
29. S. Dedeurwaerdere K. Vonck P. Van Hese W. Wadman P. Boon The acute and chronic effect of vagus nerve stimulation on spike and wave discharges in "Genetic Absence Epilepsy Rats from Strasbourg" (GAERS) Epilepsia 46 Suppl 5 2005 94-97
30. F. Dufour K.A. Nalecz M.J. Nalecz A. Nehlig Modulation of absence seizures by branched-chain amino acids: Correlation with brain amino acid concentrations Neurosci Res 40 2001 255-263
31. 2+ currents Seizure 10 2001 279-286
32. W. Loscher D. Honack P. Bloms-Funke The novel antiepileptic drug levetiracetam (ucb L059) induces alterations in GABA metabolism and turnover in discrete areas of rat brain and reduces neuronal activity in substantia nigra pars reticulata Brain Res 735 1996 208-216
33. B. Feddersen C. Deransart L. Vercueil S. Noachtar A. Depaulis High-frequency stimulation of the substantia nigra pars reticulata suppresses absence seizures in a genetic model of absence epilepsy in the rat Epilepsia 45 2004 118
34. A. Nehlig M. Vergnes S. Boyet C. Marescaux Metabolic activity is increased in discrete brain regions before the occurrence of spike-and-wave discharges in weanling rats with genetic absence epilepsy Brain Res Dev Brain Res 108 1998 69-75